Chapter 15 - Thyroid, Parathyroid Flashcards

1
Q

How many thyroid nodules found on PET will be found to be malignant?

A

As many as 2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Initial workup of palpable thyroid nodule

A

U/S
Laryngoscopy
Thyroid function assay, calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most common malignancy of thyroid

A

PTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common neoplasm of thyroid

A

follicular adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Percentage of pop with thyroid nodules palpable

Percentage of these that are cancer (and things that increase risk)

A

4-7%
5-10%
<30 >60, male, FHx, rads as child, high TSH/Hashimoto, rapid grow, pain, compression sx, hoarse, cervical LAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What features on U/S make you FNA a nodule?

A
>1cm OR:
microcalcification
irregular margin
solid (not cystic)
internal vascularity
multiple nodules
ipsilateral cervical LAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnostic accuracy of FNA

A

95%
False neg 2.3%
False pos 1.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TIRADS Classification (u/s)

A

1- NL
2- Benign (simple cyst, spongiform nodule, isolated macrocalcify, subacute thyroiditis). 3- Probably benign (isoechogenic, hyperechogenic)
4A- low suspicion (moderately hypoechogenic)
4B- 1-2 high risk signs and no adenopathy
5- 3+ signs and/or adenopathy. >80% risk malignant
High risk Signs: Taller than wide, irregular/microlobulated margins, microcalcify, marked hypoechogenicity
6- Biopsy proven malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FNA reporting of thyroid. Classification

A

Benign - 70%
Malignant - 5%
Suspicious- 10%
Indeterminate- 15%

10-20% of suspicious will be follicular CA
May do molecular testing on indeterminate (Mutation panel, gene expression testing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mutation panel testing for thyroid cancer, and gene expression testing

A

100% PPV (rule in), but 30% don’t have a mutation
RAS, PPARg, RET/PTC, BRAF

GET: 142 genes, rules out, NPV >95%, $3,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How to follow benign nodule

A

Serial u/s q6-12 mo
repeat FNA if significant change
If cysts return after multiple FNA, consider removal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Percentage of occurrence of all thyroid CA

A
PTC 70-85%
Foll CA 15-20%
Huerthle 2-5%
MTC 3-10%
Anaplastic <2%
Insular/poorly differentiated (rare)
Lymphoma, SCC, mets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T Staging thyroid CA

A
T1a 1cm
1b 1-2cm
T2 2-4cm
T3 >4cm
4a: to ST, larynx, trachea, esophagus, RLN
4b: beyond above regions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

N Staging thyroid

A

1a- spread to central (pretracheal, paratracheal, prelaryngeal)
1b- beyond central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Staging of PTC or FTC <45 yo

A

I: Anything less than M1
II: M1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Staging of PTC, FTC >45 yo

A
I: T1
II: T2-3
III: T4 or N1a
IVa: 4a, or N1b
IVb: 4b
IVc: M1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Low risk prognosis for thyroid cancer (AMES)

A

Age <40/50 (m/f), tumor <4cm, within thyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

High risk prognosis thyroid: AMES and MACIS

A

Age >41/51 (m/f), extrathyroid, >5cm

Age >40, invasion of gland, incomplete resection, >4cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Near total vs sub-total thyroidectomy

A

Near: leave SMALL amount thyroid tissue around parathyroids, RLN to reduce morbidity
Sub: large amounts of thyroid left

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment of Stage I-II PTC, Foll CA?

A

Total thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Treatment Stage III PTC, FTC

A

Total thyroid plus removal of involved LN/other sites of thyroid dz
I-131 ablate if demonstrates uptake, or external beam rads if I-131 uptake is minimal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Treatment Stage IV PTC, FTC

A

total thyroid, neck
Ablate with I-131 or Rads or chemo (VEGF inh)
May remove mets with no I-131 uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which thyroid CA does not spread to LN often?

A

Follicular

Papillary and Medullary do, eval central and II-IV, some authors say do central if PTC >3cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

MEN I, IIa, IIb

A

I- para, pit, panc
IIa- MTC, pheo, para (RET)
IIb- MTC, pheo, mucosal neuromas (RET), most aggressive medullary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How does medullary behave differently?
Aggressive Secrete calcitonin, CEA, prostaglandin, serotonin, histaminase Incades muscle, trachea, heme spread to lungs/viscera (50% @ pres) 30% are familial/genetic
26
How to screen for Pheo
All patients with medullary get RET testing | If positive, do 24 hr urine catecholamine, abdominal scan
27
How to screen for parathyroid adenoma
serum calcium, PTH | Sestamibi
28
Imaging workup in patients with medullary
MRI, PET, sestamibi, indium-labeled somatostatin scans
29
Treatment and f/u for medullary
total thyroid plus other involved areas | f/u calcitonin, CEA
30
Describe anaplastic thyroid CA
80% occur in pre-existing mass Sudden growth, pain, hoarse, dysphagia, dyspnea All are stage IV (a to nearby, b beyond nearby, c mets)
31
Treatment and survival of anaplastic
Median survival less than 6 mo | Doxorubicin, Rads, debulking surg, trach
32
What to consider when deciding to do RAI
Size, lymphovascular invasion, invade thyroid capsule, LN
33
Thyroid cancer recurrence statistics
10-30% recur/metastasize 80% recurrences in neck alone (otherwise lungs) 50% cured with second operation If recur by I-131 and not clinically apparent, good prognosis, Tx with I-131 Multi-tyrosine kinase INH if not resp to I-131
34
How many have 5-7 parathyroid glands? And fewer than 4?
3-7% | 3-5%
35
Average weight of parathyroid, diameter, blood supply
35-50 mcg 1-5mm ITA (rarely posterior br STA)
36
Causes of primary hyperpara
solitary adenoma (85%) multiple hyperplastic glands (10-15%) multiple adenomas (3-4%) carcinoma (<1%) Overexpression PRAD1 oncogene, low-dose rads exposure may be responsible
37
Secondary and tertiary hyperpara
2: CRF, Surg if osteopenia (3 1/2 removal), May use cinacalcet 3: autonomous para
38
Sx of hypercalcemia
``` GI- nausea, constip, ulcer, pancreatitis Mm weak Stones HTN, arrhythmia Polydipsia Depress, tired, memory ```
39
DDx hyperCa
``` Mets from BLTKP MM SCLC, ovarian, thymoma Gloma Thiazides, lithium, theophylline, hypervit A/D Immobile Milk-Alkali Fam Hypocalciuric hyperCa Hyperphosphatasia Pagets ```
40
Elevated PTH but normal calcium - causes
Vitamin D Insuff | Malabsorption
41
Imaging options for primary hyperpara
T99 sestamibi - to mitochondria, 2 hours later out of thyroid. 100 Se 90 Sp ``` T99 MIBI SPECT-3D T99 thallium subtraction U/S, FP 15-20% MRI (T2) Intraop gamma Angiography Venous sample FNA ```
42
Ectopic para locations
Sup Med, thymic capsule, retro-esoph, carotid sheath, medial to sup thyroid pole Sup para usually near lateral lobe. Inferior more variable
43
When to perform surgery in asymptomatic primary hyperpara
``` Serum Ca 1 above NL GFR <60 T score <2.5 or prior fx/fragile <50 Patient wants surgery, cannot be reliably followed ```
44
Intraop PTH monitoring
1/2 life 3-5 min | Want see decrease by 50% 10 min after removal of adenoma/hyperplasia
45
Autotransplant para
Immediate or up to 18 mo frozen SCM, brachioradialis Fxn within 3 m, success rate 50% Arm: can remove under local if hyperplasia
46
When could it be appropriate to do lobectomy for thyroid CA
<1cm low risk papillary CA | 5-10% recur c/l
47
When to not do RAI, risks of RAI
No benefit if complete resection, no nodes, T1-2, >45 Second CA, Sialadenitis, Lacrimal, Salivary Dysfxn Give with rhTSH to decrease risk
48
Parathyroid re-exploration
``` SCM to retroesoph Thymus PVS Thyroid lobe palpate Open sheath hyoid to mediastinum Explore Sup Mediastinum ```
49
Which cancers go to 1a?
Oral tongue, FOM, lower gum/lip
50
Which cancers go to 1b?
OC (buccal, tongue, lateral FOM) Anterior nasal cavity Max sinus SM gl
51
Which cancers go to 2?
OC, nose, NP, OP, HP, larynx, parotid
52
Which cancers go to 3?
OC, OP, NP, HP, larynx
53
Which cancers go to 4?
HP, thyroid, larynx, esophagus
54
Which cancers go to 5?
Skin post scalp/neck, NP, OP
55
Which cancers go to 6?
Thyroid, larynx (glott, subglott), esophagus, piriform sinus apex
56
Nasopharyngeal nodal staging
1: unilat, <6cm, above supraclav 2: bilat 3: >6 or to supraclavicular fossa (b)
57
Deficit from injured XI
Can’t raise shoulder above 90 degrees, shoulder pain
58
If need to remove both IJ, how long do you wait?
2 weeks to remove second one 10% die when simultaneous
59
Which neck dissection to do for: OC
1-3
60
Which neck dissection to do for: OP, HP, Lar
2-4 (Lat)
61
Which neck dissection to do for: post scalp
2-5, retroauric, Suboccip (PL neck diss)
62
Which neck dissection to do for: Ant/lat face
1-3, parotid, facial
63
Which neck dissection to do for: Thyroid, esoph, advanced laryngeal
6
64
Chyle Leak
Occurs 1-2% Duct enters IJ sup to jxn with subclavian Surgery if >500cc/day (May do TPN instead) Less- pressure dressing, low fat diet, drainage
65
Cause of SIADH after IJ ligation
Cerebral edema
66
Which patients are at risk for facial/cerebral edema after ND?
Prior Rads, IJ ligation
67
Things that INC risk of carotid blowout
``` Salivary fistula Flap breakdown (prior Rads) Malnutrition, Infxn, diabetes ```
68
When to do neck dissection along with chemo Rads
N2b/3 N1-2 and persistent nodal Disease 3mo after Tx
69
When to do open biopsy rather than FNA for suspected cancer in node
Only if suspected lymphoma
70
Sacrifice carotid?
If you assess COW collaterals (balloon occlusion, xenon inhalation CT) then CNS compl 12%, 1 year disease free survival 45%, 2 year 22%.
71
When to consider postop radiation
ECS, multiple positive nodes
72
When to do MRND for salvage rather than SND
Fixate, infiltrate surrounding tissue from nodal Mets